Douglas Buethe, MD
Dermatology · Cleveland, OHNPI 1669767315
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $724 of the $824 with a category attached, or 87.9%. It is spread thinly across 12 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in OH, where the typical reported total is $2,374.
Across 41 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$175
- Dermavant Sciences, Inc.$137
- Novartis$120
- Lilly USA, LLC$101
- AbbVie$69
- Incyte Corporation$66
- plus $157 from 6 others
What the payments were for
- Food & beverage$72488%
- Education$10012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $175 |
| Dermavant Sciences, Inc. | 8 | $137 |
| Novartis | 6 | $120 |
| Lilly USA, LLC | 5 | $101 |
| AbbVie | 4 | $69 |
| Incyte Corporation | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Bristol Myers Squibb | 1 | $25 |
| Sanofi | 1 | $23 |
| Abbott | 1 | $20 |
| Smith+Nephew | 1 | $16 |
How this compares
$824 in reported general payments places this provider in the 30th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 21 | $421,531 |
| Humira(Cf) PenAdalimumab | 21 | $283,720 |
| Tacrolimus | 140 | $15,930 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 120 | $5,447 |
| Fluocinonide | 147 | $5,174 |
| Fluorouracil | 60 | $4,293 |
| Tretinoin | 74 | $3,616 |
| Clobetasol Propionate | 90 | $3,590 |
| Triamcinolone Acetonide | 213 | $3,000 |
| Ketoconazole | 210 | $2,818 |
| Doxycycline Hyclate | 150 | $2,626 |
| Calcipotriene | 20 | $1,777 |
| Metronidazole | 30 | $1,687 |
| Clindamycin Phosphate | 44 | $1,229 |
| Mometasone Furoate | 28 | $1,083 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cleveland
- Neil KormanCleveland$824K
- Shilpi KhetarpalCleveland$383K
- Anthony FernandezCleveland$352K
- Alex HirshCleveland$159K
- Mara Weinstein VelezCleveland$96K
- Samantha PollyCleveland$80K
- Wilma BergfeldCleveland$35K
- David HamrockCleveland$19K
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.